InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (3 ops.)
Insider track record
Board DirectorDisclosed buys
6
Disclosed sells
3
T+90 hit rate
17%
T+90 mean return
-18.2%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Walker Paul Edward, Director. Director active across 12 companies, notably Monte Rosa Therapeutics, Inc.. Cumulatively, 19 reports have been published. Breakdown: 6 buys · 3 sells. Total volume traded: €9.9m. History available since 17 November 2021. The latest transaction was disclosed on 22 April 2024 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations19 total
2,760,860 sharesCommon StockSEC:0000950170-25-072714:0
1,023,103 sharesCommon StockSEC:0000950170-24-107544:0
17,857 shares@ US$56.00100.0% of flowCommon StockSEC:0000950170-24-047683:0
Ideal exit: 17 Jan 2025 (T+270)
333,333 shares@ US$3.00100.0% of flowCommon StockSEC:0001209191-23-042804:0
Ideal exit: 12 Apr 2024 (T+270)
2,000,000 shares0Common StockSEC:0001209191-23-037366:0
4,294,207 sharesCommon StockSEC:0001209191-22-059461:0
597,600 shares@ US$5.02100.0% of flowCommon StockSEC:0001209191-22-051146:0
Ideal exit: 18 Jun 2023 (T+270)
5,931,843 shares@ US$0.0654100.0% of flowCommon StockSEC:0001209191-22-032331:0
2,631,578 shares@ US$1.900.23% mcap100.0% of flowCommon StockSEC:0001209191-22-024322:0
Ideal exit: 6 Jan 2023 (T+270)
37,570 shares@ US$1.32150.0% of flowCommon StockSEC:0001209191-21-071274
37,570 shares@ US$1.32150.0% of flowCommon StockSEC:0001209191-21-071274:0
5,736,363 shares0Common SharesSEC:0001209191-21-065762
5,736,363 shares0Common SharesSEC:0001209191-21-065762:0
1,851,852 sharesCommon StockSEC:0001209191-21-061098:0
Ideal exit: 15 Jul 2022 (T+270)
1,851,852 sharesCommon StockSEC:0001209191-21-061098
Ideal exit: 15 Jul 2022 (T+270)
2,715,968 sharesCommon StockSEC:0001209191-21-044050
5,864,718 sharesCommon StockSEC:0001209191-21-044200
2,715,968 sharesCommon StockSEC:0001209191-21-044050:0
5,864,718 sharesCommon StockSEC:0001209191-21-044200:0
19 of 19 declarations
About Walker Paul Edward
Walker Paul Edward is a Board Member of Monte Rosa Therapeutics, Inc., Bright Health Group Inc., and Trevi Therapeutics, Inc. With experience in the healthcare and biotechnology sectors, he contributes to the governance and development strategy of the companies. Paul is recognized for his expertise in innovation and research, which is essential for the growth of the companies.
